Laura Davis, PA
Physician Assistant · Shelbyville, KYNPI 1366693905
Payments from drug & device makers
Across 255 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$830
- Lilly USA, LLC$533
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$369
- Novo Nordisk$307
- Vanda Pharmaceuticals Inc.$291
- Pfizer$262
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $830 |
| Lilly USA, LLC | 29 | $533 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $369 |
| Novo Nordisk | 20 | $307 |
| Vanda Pharmaceuticals Inc. | 15 | $291 |
| Pfizer | 15 | $262 |
| GSK | 12 | $198 |
| AstraZeneca | 7 | $180 |
| Amgen | 8 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Dynavax Technologies Corporation | 5 | $86 |
| Verona Pharma, Inc. | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Novartis | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Johnson & Johnson | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Astellas Pharma US Inc | 3 | $52 |
| Bayer | 3 | $52 |
| Alkermes, Inc. | 2 | $49 |
| Exact Sciences | 3 | $41 |
| Insulet Corporation | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| BETA Bionics, Inc. | 1 | $31 |
| Tonix Medicines, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
| Almatica Pharma LLC | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Abiomed | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Merck | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Abbott | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
How this compares
$4,266 in reported general payments places this provider in the 90th percentile of 1,448 physician assistant providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 97 | $87,027 |
| MounjaroTirzepatide | 65 | $69,300 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $36,856 |
| OzempicSemaglutide | 27 | $34,301 |
| FarxigaDapagliflozin Propanediol | 36 | $27,341 |
| JanuviaSitagliptin Phosphate | 17 | $18,360 |
| VraylarCariprazine Hcl | 11 | $15,811 |
| TrulicityDulaglutide | 14 | $13,440 |
| JardianceEmpagliflozin | 13 | $12,329 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 26 | $12,182 |
| InvokanaCanagliflozin | 13 | $7,136 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $6,782 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $6,256 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 48 | $5,243 |
| Varenicline Tartrate | 12 | $4,950 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $262 | $87,02797 claims |
| Lilly USA, LLCMounjaro, Trulicity | $533 | $82,74079 claims |
| GSKTrelegy Ellipta | $198 | $36,85642 claims |
| Novo NordiskOzempic | $307 | $34,30127 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat | $15 | $30,76752 claims |
| AstraZenecaFarxiga | $180 | $27,34136 claims |
| MerckJanuvia | $17 | $18,36017 claims |
| AbbVieVraylar, Synthroid | $830 | $17,31643 claims |
| Johnson & JohnsonInvokana | $54 | $7,13613 claims |
| Almatica Pharma LLCSertraline Hcl | $25 | $40682 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,448 physician assistant providers in Kentucky.
Other physician assistant in Shelbyville
- Brandice HarrisonLexington$745K
- Lauren MeadeLexington$656K
- Melissa DavisLouisville$362K
- Kara MuddLouisville$98K
- Seth KingBowling Green$91K
- Marty MullinsHazard$63K
- Lauri GarnerVersailles$33K
- Robert TatumLouisville$29K
- Michelle JonesLexington$29K
- Grace IsaacsLouisville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.